Probiotic Supplement for the Prevention of Gestational Diabetes: A Meta-Analysis of Randomized Controlled Trials

Abstract

Background Probiotic supplements may have some potential in preventing gestational diabetes, and this meta-analysis aims to explore the efficacy of probiotic supplements to prevent gestational diabetes.

Methods PubMed, EMbase, Web of science, EBSCO, and Cochrane library databases were systematically searched, and we included randomized controlled trials (RCTs) assessing the effect of probiotic supplements on the incidence of gestational diabetes mellitus. Meta-analysis was performed using the fixed-effect or random-effect model as appropriate.

Results Six RCTs were finally included in the meta-analysis. Overall, compared with control intervention in pregnant women, probiotic supplementation intervention showed no obvious impact on the incidence of gestational diabetes (OR=0.68; 95% CI=0.39 to 1.20; P=0.18), fasting plasma glucose (SMD=−0.05; 95% CI=−0.29 to 0.19; P=0.69), 2 h-OGTT (SMD=−0.07; 95% CI=−0.27 to 0.13; P=0.47), gestational age (SMD=0.04; 95% CI=−0.14 to 0.21; P=0.69) or preeclampsia (OR=1.22; 95% CI=0.83 to 1.78; P=0.31).

Conclusions Probiotic supplementation was confirmed to have no benefits for the prevention of gestational diabetes.

Key words

probiotic supplement - gestational diabetes - prevention

Publication History

Received: 19 May 2022

Accepted after revision: 23 September 2022

Article published online:
11 November 2022

• References

• 1 Mijatovic-Vukas J, Capling L, Cheng S. et al. Associations of diet and physical activity with risk for gestational diabetes mellitus: a systematic review and meta-analysis. Nutrients 2018; 10: 698 DOI: 10.3390/nu10060698.
• 2 Vounzoulaki E, Khunti K, Abner SC. et al. Progression to type 2 diabetes in women with a known history of gestational diabetes: systematic review and meta-analysis. BMJ 2020; 369: m1361 DOI: 10.1136/bmj.m1361.
• 3 Wei W, He Y, Wang X. et al. Gestational diabetes mellitus: the genetic susceptibility behind the disease. Horm Metab Res 2021; 53: 489-498 DOI: 10.1055/a-1546-1652.
• 4 Baloch P, Nawaz N, Maqsood S. et al. Effect of probiotics on preventing gestational diabetes among high-risk pre-diabetic pregnant women: A randomized controlled trial. Ann Romanian Soc Cell Biol 2022; 26: 406-413
• 5 Nguyen BT, Cheng YW, Snowden JM. et al. The effect of race/ethnicity on adverse perinatal outcomes among patients with gestational diabetes mellitus. Am J Obstet Gynecol 2012; 207: 322.e321-326 DOI: 10.1016/j.ajog.2012.06.049.
• 6 Lende M, Rijhsinghani A. Gestational diabetes: Overview with emphasis on medical management. Int J Environ Res Public Health 2020; 17: 9573 DOI: 10.3390/ijerph17249573.
• 7 Kim C, Newton KM, Knopp RH. Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes Care 2002; 25: 1862-1868
• 8 Sivan E, Maman E, Homko CJ. et al. Impact of fetal reduction on the incidence of gestational diabetes. Obstet Gynecol 2002; 99: 91-94
• 9 Al-Badri MR, Zantout MS, Azar ST. The role of adipokines in gestational diabetes mellitus. Ther Adv Endocrinol Metab 2015; 6: 103-108 DOI: 10.1177/2042018815577039.
• 10 Nicklas JM, Skurnik G, Zera CA. et al. Employing a multi-level approach to recruit a representative sample of women with recent gestational diabetes mellitus into a randomized lifestyle intervention trial. Matern Child Health J 2016; 20: 261-269 DOI: 10.1007/s10995-015-1825-8.
• 11 Ebrahimzadeh M, Ebrahimzadeh Zagami S, Kordi M. et al. Effect of probiotic capsules on preventing gestational diabetes among high-risk prediabetic pregnant women. Iran J Obstet Gynecol Infertil 2020; 23: 57-66 DOI: 10.22038/ijogi.2020.15964.
• 12 Bansal T, Alaniz RC, Wood TK. et al. The bacterial signal indole increases epithelial-cell tight-junction resistance and attenuates indicators of inflammation. Proc Natl Acad Sci U S A 2010; 107: 228-233 DOI: 10.1073/pnas.0906112107.
• 13 Hajifaraji M, Dolatkhah NJ. Probiotics and metabolic outcomes of gestational diabetes: A review article. J Mazandaran Univ Med Sci 2018; 28: 155-174
• 14 Koren O, Goodrich JK, Cullender TC. et al. Host remodeling of the gut microbiome and metabolic changes during pregnancy. Cell 2012; 150: 470-480 DOI: 10.1016/j.cell.2012.07.008.
• 15 Yadav H, Jain S, Sinha PR. Antidiabetic effect of probiotic dahi containing Lactobacillus acidophilus and Lactobacillus casei in high fructose fed rats. Nutrition 2007; 23: 62-68 DOI: 10.1016/j.nut.2006.09.002.
• 16 Bain E, Crane M, Tieu J. et al. Diet and exercise interventions for preventing gestational diabetes mellitus. Cochrane Database Syst Rev 2015; CD010443 DOI: 10.1002/14651858.CD010443.pub2.
• 17 Lambert JM, Bongers RS, de Vos WM. et al. Functional analysis of four bile salt hydrolase and penicillin acylase family members in Lactobacillus plantarum WCFS1. Appl Environ Microbiol 2008; 74: 4719-4726 DOI: 10.1128/AEM.00137-08.
• 18 Facchinetti F, Dante G, Petrella E. et al. Dietary interventions, lifestyle changes, and dietary supplements in preventing gestational diabetes mellitus: a literature review. Obstet Gynecol Surv 2014; 69: 669-680 DOI: 10.1097/OGX.0000000000000121.
• 19 Shahriari A, Karimi E, Shahriari M. et al. The effect of probiotic supplementation on the risk of gestational diabetes mellitus among high-risk pregnant women: A parallel double-blind, randomized, placebo–controlled clinical trial. Biomed Pharmacother 2021; 141: 111915 DOI: 10.1016/j.biopha.2021.111915.
• 20 Asgharian H, Homayouni-Rad A, Mirghafourvand M. et al. Effect of probiotic yoghurt on plasma glucose in overweight and obese pregnant women: a randomized controlled clinical trial. Eur J Nutr 2020; 59: 205-215 DOI: 10.1007/s00394-019-01900-1.
• 21 Moher D, Liberati A, Tetzlaff J. et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 2009; 339: b2535 DOI: 10.1136/bmj.b2535.
• 22 Higgins JPT, Green S. (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.handbook.cochrane.org
• 23 Jadad AR, Moore RA, Carroll D. et al. Assessing the quality of reports of randomized clinical trials: Is blinding necessary?. Control Clin Trials 1996; 17: 1-12 DOI: 10.1016/0197-2456(95)00134-4.
• 24 Kjaergard LL, Villumsen J, Gluud C. Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses. Ann Intern Med 2001; 135: 982-989 DOI: 10.7326/0003-4819-135-11-200112040-00010.
• 25 Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002; 21: 1539-1558 DOI: 10.1002/sim.1186.
• 26 Pellonperä O, Mokkala K, Houttu N. et al. Efficacy of fish oil and/or probiotic intervention on the incidence of gestational diabetes mellitus in an at-risk group of overweight and obese women: a randomized, placebo-controlled, double-blind clinical trial. Diabetes Care 2019; 42: 1009-1017 DOI: 10.2337/dc18-2591.
• 27 Callaway LK, McIntyre HD, Barrett HL. et al. Probiotics for the prevention of gestational diabetes mellitus in overweight and obese women: findings from the SPRING double-blind randomized controlled trial. Diabetes Care 2019; 42: 364-371 DOI: 10.2337/dc18-2248.
• 28 Wickens KL, Barthow CA, Murphy R. et al. Early pregnancy probiotic supplementation with Lactobacillus rhamnosus HN001 may reduce the prevalence of gestational diabetes mellitus: a randomised controlled trial. The Br J Nutr 2017; 117: 804-813 DOI: 10.1017/S0007114517000289.
• 29 Gomes AC, Bueno AA, de Souza RG. et al. Gut microbiota, probiotics and diabetes. Nutr J 2014; 13: 60 DOI: 10.1186/1475-2891-13-60.
• 30 Tieu J, Shepherd E, Middleton P. et al. Dietary advice interventions in pregnancy for preventing gestational diabetes mellitus. Cochrane Database Syst Rev 2017; 1: CD006674 DOI: 10.1002/14651858.CD006674.pub3.
• 31 Oostdam N, van Poppel MN, Wouters MG. et al. Interventions for preventing gestational diabetes mellitus: a systematic review and meta-analysis. J Womens Health (Larchmt) 2011; 20: 1551-1563 DOI: 10.1089/jwh.2010.2703.
• 32 Sanz Y, Santacruz A, Gauffin P. Gut microbiota in obesity and metabolic disorders. Proc Nutr Soc 2010; 69: 434-441 DOI: 10.1017/S0029665110001813.
• 33 VandeVusse L, Hanson L, Safdar N. Perinatal outcomes of prenatal probiotic and prebiotic administration: an integrative review. J Perinat Neonatal Nurs 2013; 27: 288-301 quiz E281–282 DOI: 10.1097/JPN.0b013e3182a1e15d.
• 34 Asemi Z, Zare Z, Shakeri H. et al. Effect of multispecies probiotic supplements on metabolic profiles, hs-CRP, and oxidative stress in patients with type 2 diabetes. Ann Nutr Meta 2013; 63: 1-9 DOI: 10.1159/000349922.
• 35 Pan J, Pan Q, Chen Y. et al. Efficacy of probiotic supplement for gestational diabetes mellitus: a systematic review and meta-analysis. J Matern Fetal Neonatal Med 2019; 32: 317-323 DOI: 10.1080/14767058.2017.1376318.
• 36 Kim SY, England L, Sappenfield W. et al. Racial/ethnic differences in the percentage of gestational diabetes mellitus cases attributable to overweight and obesity, Florida, 2004–2007. Prev Chronic Dis 2012; 9: E88
• 37 Kim SY, England L, Wilson HG. et al. Percentage of gestational diabetes mellitus attributable to overweight and obesity. Am J Public Health 2010; 100: 1047-1052 DOI: 10.2105/AJPH.2009.172890.